Patiromer Acetate Induced Hypercalcemia: An Unreported Adverse Effect
Hyperkalemia, a potential life threating condition, is a commonly encountered problem in chronic kidney disease (CKD) patients. Patiromer acetate, a nonabsorbable cation exchange polymer, is a gastrointestinal agent for chronic therapy in patients with persistent hyperkalemia. Patiromer is generally...
Saved in:
Main Authors: | Shreeyukta Bhattarai, Stephen Pupillo, Gulshan Man Singh Dangol, Erdal Sarac |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Case Reports in Nephrology |
Online Access: | http://dx.doi.org/10.1155/2019/3507407 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hypercalcemia of Malignancy in Thymic Carcinoma: Evolving Mechanisms of Hypercalcemia and Targeted Therapies
by: Cheng Cheng, et al.
Published: (2017-01-01) -
Hypercalcemia: An Unusual Manifestation of Uterine Leiomyoma
by: Amarinder Singh Garcha, et al.
Published: (2013-01-01) -
Planning and Implementation of Active Leakage Control in the Management of Unreported Leakages
by: Mahmut Fırat, et al.
Published: (2022-07-01) -
Unforeseen Hodgkin Lymphoma Hidden behind Hypercalcemia
by: Moutaz Ghrewati, et al.
Published: (2019-01-01) -
Autoclave reactor synthesis of upconversion nanoparticles, unreported variables, and safety considerations
by: Rebecca McGonigle, et al.
Published: (2025-02-01)